DrugDashboards

Ketotifen Fumarate

Ketotifen Fumarate · KETOTIFEN FUMARATE .25 mg/mL · Solution · Ophthalmic · Unichem Pharmaceuticals (USA), Inc.

NDC 76385-0106-17 · 1 BOTTLE, PLASTIC in 1 CARTON / 5 mL in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. The generic price has held steady around $1.30 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00Feb 2022Sep 2026$1.30
56 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$8.80
Reported to Texas DSHS · 2026 annual filing · Bayshore Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$1.8M
128,849 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for ketotifen fumarate (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA204059
TE code
Approval date
Jun 1, 2020
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ketotifen Fumarate (Solution)

LabelerStrengthFirst seenLast seen
Alcon Laboratories, Inc.KETOTIFEN FUMARATE .25 mg/mLJul 15, 2026Sep 2, 2026
Cardinal HealthKETOTIFEN FUMARATE .25 mg/mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.KETOTIFEN FUMARATE .25 mg/mLJul 15, 2026Sep 2, 2026
Redpharm DrugKETOTIFEN FUMARATE .25 mg/mLJul 15, 2026Sep 2, 2026
SafewayKETOTIFEN FUMARATE .25 mg/mLJul 15, 2026Sep 2, 2026
Target CorporationKETOTIFEN FUMARATE .25 mg/mLJul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.KETOTIFEN FUMARATE .25 mg/mLJul 15, 2026Sep 2, 2026
Wal-Mart Stores, Inc.KETOTIFEN FUMARATE .25 mg/mLJul 15, 2026Sep 2, 2026
Walgreen CompanyKETOTIFEN FUMARATE .35 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ketotifen Fumarate — NDC 76385-0106-17," retrieved September 3, 2026, https://drugdashboards.com/drug/76385010617.

Free to cite with attribution — see how the data is put together.